Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 2
2007 4
2008 2
2010 3
2011 4
2012 8
2013 6
2014 6
2015 5
2016 4
2017 8
2018 10
2019 10
2020 11
2021 10
2022 8
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. Among authors: papadopoulos eb. J Clin Oncol. 2024 Mar 12:JCO2302474. doi: 10.1200/JCO.23.02474. Online ahead of print. J Clin Oncol. 2024. PMID: 38471061
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Stahl M, Derkach A, Farnoud N, Bewersdorf JP, Robinson T, Famulare C, Cho C, Devlin S, Menghrajani K, Patel MA, Cai SF, Miles LA, Bowman RL, Geyer MB, Dunbar A, Epstein-Peterson ZD, McGovern E, Schulman J, Glass JL, Taylor J, Viny AD, Stein EM, Getta B, Arcila ME, Gao Q, Barker J, Shaffer BC, Papadopoulos EB, Gyurkocza B, Perales MA, Abdel-Wahab O, Levine RL, Giralt SA, Zhang Y, Xiao W, Pai N, Papaemmanuil E, Tallman MS, Roshal M, Goldberg AD. Stahl M, et al. Among authors: papadopoulos eb. Am J Hematol. 2023 Jan;98(1):79-89. doi: 10.1002/ajh.26757. Epub 2022 Oct 31. Am J Hematol. 2023. PMID: 36251406 Free PMC article.
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.
Tamari R, Scordo M, Kunvarjee BM, Proli A, Lin A, Flynn J, Cho C, Devlin S, Klein E, Boulad F, Cancio MI, Curran KJ, Jakubowski AA, Kernan NA, Kung AL, O'Reilly RJ, Papadopoulos EB, Prockop S, Scaradavou A, Shaffer BC, Shah G, Spitzer B, Gyurkocza B, Giralt SA, Perales MA, Boelens JJ. Tamari R, et al. Among authors: papadopoulos eb. Blood Adv. 2023 Sep 26;7(18):5225-5233. doi: 10.1182/bloodadvances.2023009708. Blood Adv. 2023. PMID: 37379285 Free PMC article.
Ionizing radiation exposure after allogeneic hematopoietic cell transplantation.
Cho C, Maloy MA, Devlin SM, Aras O, Dauer LT, Jakubowski AA, Papadopoulos EB, Perales MA, Rappaport TS, Giralt SA. Cho C, et al. Among authors: papadopoulos eb. Bone Marrow Transplant. 2022 May;57(5):827-829. doi: 10.1038/s41409-022-01612-x. Epub 2022 Feb 19. Bone Marrow Transplant. 2022. PMID: 35184148 Free PMC article. No abstract available.
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation.
Lin A, Brown S, Maloy M, Ruiz JD, Devlin S, DeRespiris L, Proli A, Jakubowski AA, Papadopoulos EB, Sauter CS, Tamari R, Castro-Malaspina H, Shaffer B, Barker J, Perales MA, Giralt SA, Gyurkocza B. Lin A, et al. Among authors: papadopoulos eb. Leuk Lymphoma. 2022 Jul;63(7):1686-1693. doi: 10.1080/10428194.2022.2032036. Epub 2022 Feb 10. Leuk Lymphoma. 2022. PMID: 35142567 Free PMC article.
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.
Lakkaraja M, Scordo M, Mauguen A, Cho C, Devlin S, Ruiz JD, Klein E, Avecilla ST, Boulad F, Cancio MI, Curran KJ, Jakubowski AA, Kernan NA, Kung AL, O'Reilly RJ, Papadopoulos EB, Prockop S, van Roessel I, Scaradavou A, Shaffer BC, Shah G, Spitzer B, Tamari R, Giralt SA, Perales MA, Boelens JJ. Lakkaraja M, et al. Among authors: papadopoulos eb. Blood Adv. 2022 Feb 8;6(3):1054-1063. doi: 10.1182/bloodadvances.2021005584. Blood Adv. 2022. PMID: 34788361 Free PMC article.
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
Elias S, Brown S, Devlin SM, Barker JN, Cho C, Chung DJ, Dahi PB, Giralt S, Gyurkocza B, Jakubowski AA, Lahoud OB, Landau H, Lin RJ, Papadopoulos EB, Politikos I, Ponce DM, Scordo M, Shaffer BC, Shah GL, Tamari R, Young JW, Perales MA, Shouval R. Elias S, et al. Among authors: papadopoulos eb. Br J Haematol. 2023 Dec;203(5):840-851. doi: 10.1111/bjh.19055. Epub 2023 Aug 24. Br J Haematol. 2023. PMID: 37614192
CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era.
Vaughn JL, Brown S, Papadopoulos EB, Jakubowski AA, Tamari R, Giralt SA, Ponce DM, Cho C, Perales MA, Shaffer BC, Gyurkocza B. Vaughn JL, et al. Among authors: papadopoulos eb. Bone Marrow Transplant. 2022 Nov;57(11):1740-1742. doi: 10.1038/s41409-022-01783-7. Epub 2022 Sep 8. Bone Marrow Transplant. 2022. PMID: 36076011 No abstract available.
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.
Shouval R, Fein JA, Cho C, Avecilla ST, Ruiz J, Tomas AA, Sanchez-Escamilla M, Flores NC, Yáñez L, Barker JN, Dahi P, Giralt SA, Geyer AI, Gyurkocza B, Jakubowski AA, Lin RJ, O'Reilly RJ, Papadopoulos EB, Politikos I, Ponce DM, Sauter CS, Scordo M, Shaffer B, Shah GL, Sullivan JP, Tamari R, van den Brink MRM, Young JW, Nagler A, Devlin S, Shimoni A, Perales MA. Shouval R, et al. Among authors: papadopoulos eb. Blood Adv. 2022 Mar 8;6(5):1525-1535. doi: 10.1182/bloodadvances.2021004319. Blood Adv. 2022. PMID: 34507354 Free PMC article.
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia.
Fingrut WB, Gyurkocza B, Flynn J, Davis E, Devlin S, Scaradavou A, Chinapen S, Quach S, Cho C, Giralt SA, Jakubowski AA, Lin RJ, Papadopoulos EB, Perales MA, Ponce D, Shaffer BC, Tamari R, Young JW, Politikos I, Barker JN. Fingrut WB, et al. Among authors: papadopoulos eb. Blood Adv. 2023 Aug 8;7(15):3824-3833. doi: 10.1182/bloodadvances.2022008572. Blood Adv. 2023. PMID: 36240477 Free PMC article.
87 results